1Allergologist-Immunologist: “Clinic of Allergology and Immunology”, Assistant of the Department of Polyclinic Pediatrics, Propaedeutics of
Pediatric Diseases and Postgraduate Training “Kemerovo State Medical University” of the Ministry of Health of Russia, Yurga, Russia
2Doctor of Medical Sciences, Professor, Head of the Department of Polyclinic Pediatrics, Propaedeutics of Pediatric Diseases and Postgraduate
Training “Kemerovo State Medical University”, Ministry of Health of Russia, Kemerovo, Russia
Introduction: The unfavorable trend of an increase in newly diagnosed cases of bronchial asthma (BA) in childhood is a cause for serious concern. As a rule, the atopic form of BA results from the implementation of the atopic march, for which, unfortunately, there are currently no management options.
Aim: To describe the effectiveness of long-term use of histamine antagonists and mast cell membrane stabilizers in a patient with the atopic form of BA.
Case Presentation: A clinical case is presented concerning the long-term use of cetirizine and ketotifen in the treatment of a patient with bronchial asthma, which demonstrated high efficacy. Comprehensive examination allowed for the verification of the diagnosis: (ICD-10) Bronchial asthma, atopic, moderate, controlled course (J45). Seasonal allergic rhinitis (J30). Food allergy, gastrointestinal form (allergic gastroenteritis/colitis), associated with sensitization to chicken and pork meat (K52.2). Intestinal dysbiosis, stage II, associated with UPM (Staphylococcus aureus - 105 CFU/g, Klebsiella pneumoniae - 106 CFU/g, Klebsiella oxytoca - 105 CFU/g).
Results: Considering the severity of the disease and the lack of effect from basic therapy, the patient was offered a therapeutic course of cetirizine at a dose of 10 mg once daily for up to 30 days and ketotifen 0.5 mg twice daily for up to 30 days, alternately over a period of 18 months. A multidisciplinary approach to therapy made it possible to achieve long-term clinical and laboratory remission with no respiratory symptoms up to the present time (20 years).
Conclusion: The use of a long-term course of a second-generation H1-histamine receptor blocker - cetirizine - and a mast cell membrane stabilizer with moderate H1-histamine blocking activity - ketotifen - in children with the atopic form of asthma is quite reasonable and justified in cases where inhaled glucocorticosteroids prove ineffective.
Keywords: Bronchial Asthma; Cetirizine; Ketotifen; Bacteriophages; Eosinophils; Atopy
Abbreviations: BA: Bronchial Asthma; ECP: Eosinophil Cationic Protein; IgE: Immunoglobulin E; ARVI: Acute Respiratory Viral Infections; EOS: Eosinophils; BOS: Broncho-Obstructive Syndrome; ICD-10: International Classification of Diseases, 10th Revision
Gladkov SF and Perevoshchikova NK. “Efficacy of Long-Term Use of Histamine Antagonists and Mast Cell Membrane Stabilizers in a Patient with Bronchial Asthma. Clinical Case”. EC Paediatrics 15.11 (2026): 01-07.
© 2026 Gladkov SF and Perevoshchikova NK. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Open Access by ECronicon is
licensed under a Creative Commons Attribution
4.0 International License
Based on a work at www.ecronicon.net